Phase II trial of idarubicin in patients with advanced lymphoma
- 1 May 1988
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 21 (3), 261-264
- https://doi.org/10.1007/bf00262782
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Idarubicin alone or in combination with citarabine and etoposide (3 + 3 + 5 protocol) in acute non-lymphoblastic leukaemiaLeukemia Research, 1985
- PHASE-I AND PHASE-II CLINICAL AND PHARMACOLOGICAL STUDY OF 4-DEMETHOXYDAUNORUBICIN (IDARUBICIN) IN ADULT PATIENTS WITH ACUTE-LEUKEMIA1985
- ACTIVITY AND DISTRIBUTION OF IV AND ORAL 4-DEMETHOXYDAUNORUBICIN IN MURINE EXPERIMENTAL-TUMORS1984
- Clinical evaluation of 4-demethoxydaunorubicin in patients with advanced malignant lymphoma.1983
- PHASE-I AND CLINICAL-PHARMACOLOGY STUDIES OF INTRAVENOUS AND ORAL-ADMINISTRATION OF 4-DEMETHOXYDAUNORUBICIN IN PATIENTS WITH ADVANCED CANCER1983
- Antileukemic Activity of 4-Demethoxydaunorubicin in MiceTumori Journal, 1980
- Experimental evaluation of anthracycline analogs.1979
- Comparison of Biochemical and Biological Methods in the Evaluation of New Anthracycline DrugsPublished by S. Karger AG ,1977
- Antitumor activity of 4-demethoxydaunorubicin administered orally.1977
- SYNTHESIS AND ANTITUMOR ACTIVITY OF 4-DEMETHOXYDAUNORUBICIN, 4-DEMETHOXY-7,9-DIEPIDAUNORUBICIN, AND THEIR BETA-ANOMERS1976